Health tech startup Fitterfly, which works in digital therapeutics (DTx), said it has raised $3.1 million in a pre-series A round, led by Fireside Ventures. 9Unicorns, the accelerator fund of Venture Catalysts, Venture Catalysts, and a clutch of angel investors from India, the US, and Singapore also participated in the funding round.

This is Fireside’s first investment in the booming healthtech space. The venture capital firm is known for investing in consumer brands such as boAt, Mamaearth, Yogabar, among others. Kanwaljit Singh, managing partner at Fireside Ventures will join the board of Fitterfly.

Fitterfly, with a 140-plus team, offers personalized DTx programs for diabetes, pregnancy, obesity to deliver health outcomes and offers solutions complementary to medical therapy.

“In the current post-pandemic era, we, at Fireside, believe that brands, platforms, and enterprises that address and serve well-being, holistic living, and health needs and concerns of consumers have acquired greater acceptance. Consumers are now willing to consider and adopt digital solutions that promise to improve and enhance their quality of life and keep them in a state of good health,” said Singh.

Fireside, known for building consumer-facing brands, will help strengthen the digital presence and reach of Fitterfly.

Singh added that digital therapeutics represent a significant growth opportunity for us. “…As a consumer-focused fund, we want to play a more proactive and dynamic role in building and shaping consumer behavior and the lifestyle choices they make.” Fitterfly’s DTx programs offer overall guidance on nutrition, exercise, sleep, stress, and other factors that affect health outcomes. Over 10,000 people have subscribed to its programs.